SARTORIUS STEDIM BIOTECH (4DIM)
Market Closed
14 Aug, 07:01
XMIL XMIL Primary €
185. 00
+3.6
+1.9846%
€
- Market Cap
62.48 P/E Ratio
2.92% Div Yield
0 Volume
0 Eps
€ 181.4
Previous Close Want to track 4DIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SARTORIUS STEDIM BIOTECH (4DIM) Statistics
Valuation metrics
Market Cap -
Enterprise value 17.77B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 5.1
Enterprise Value/Revenue 5.96
Enterprise Value/EBITDA 22.5
Overview
Shares outstanding -
Float 27.6M
Shares short -
% Held by insiders 0.71%
% Held by institutions 0.12%
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 151.7
52-Week high 222.4
Beta 1.09
50-Day moving average 168.31
200-Day moving average 185.36
Dividends and splits
Forward annual dividend rate 2.76
Forward annual dividend yield 0.0176%
Trailing annual dividend rate 0.69
Trailing annual dividend yield 0.0044%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 7 Apr 2026
Ex-Dividend Date 31 Mar 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.09%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.07%
Income Statement
Revenue (ttm) 2.98B
Revenue per share (ttm) 30.71
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 1.33B
EBITDA 789.8M
Net income to common (ttm) 268.1M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 521.2M
Total cash per share (mrq) 5.38
Total debt (mrq) 2.61B
Total Debt/Equity (mrq) 63.11
Current ratio (mrq) 1.03%
Book value per share (mrq) 42.04
Cash Flow
Cash flow statement 765.7M
Levered free cash flow (LFCF) 256.06M
